These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30382069)

  • 1. [Predictors of Nivolumab-Induced Skin Reactions].
    Osawa T; Inoue S; Umeda M; Hasegawa T; Makino T; Hori A; Tanaka K; Yasuda M; Mizui T; Sawa T; Sugiyama Y; Goto C
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1533-1535. PubMed ID: 30382069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma.
    Nakamura Y; Fujino T; Kagamu H; Matsuya T; Teramoto Y; Asami Y; Yamamoto A
    JAMA Dermatol; 2017 Aug; 153(8):832-834. PubMed ID: 28492864
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.
    Sowerby L; Dewan AK; Granter S; Gandhi L; LeBoeuf NR
    JAMA Dermatol; 2017 Jun; 153(6):603-605. PubMed ID: 28355425
    [No Abstract]   [Full Text] [Related]  

  • 4. Interstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma.
    Oliveira DS; Mesquita JL; Garcia YDO; Rosales YMZ; Lemes RPG; Rocha Filho FD; Fernandes PFCBC; Duarte PMA; Pitombeira MDS; Duarte FB
    Rev Assoc Med Bras (1992); 2019 Aug; 65(7):934-936. PubMed ID: 31389500
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.
    Laroche A; Alarcon Chinchilla E; Bourgeault E; Doré MA
    J Cutan Med Surg; 2018; 22(6):627-629. PubMed ID: 29772919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

  • 7. Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.
    Nakatani Y; Kawakami H; Ichikawa M; Yamamoto S; Otsuka Y; Mashiko A; Takashima Y; Ito A; Nakagawa K; Arima S
    Invest New Drugs; 2018 Aug; 36(4):726-731. PubMed ID: 29623482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome.
    Nukui T; Nakayama Y; Yamamoto M; Taguchi Y; Dougu N; Konishi H; Hayashi T; Nakatsuji Y
    J Neurol Sci; 2018 Jul; 390():115-116. PubMed ID: 29801870
    [No Abstract]   [Full Text] [Related]  

  • 9. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
    Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
    Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab therapy before vemurafenib administration induces a severe skin rash.
    Imafuku K; Yoshino K; Ymaguchi K; Tsuboi S; Ohara K; Hata H
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e169-e171. PubMed ID: 27546003
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.
    Vitale MG; Scagliarini S; Galli L; Pignata S; Lo Re G; Berruti A; Defferrari C; Spada M; Masini C; Santini D; Ciuffreda L; Ruggeri EM; Bengala C; Livi L; Fagnani D; Bonetti A; Giustini L; Hamzaj A; Procopio G; Caserta C; Sabbatini R
    PLoS One; 2018; 13(7):e0199642. PubMed ID: 29979712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.
    Mishima Y; Fukaishi T; Inase N; Isogai S
    Intern Med; 2019 Mar; 58(5):693-697. PubMed ID: 30449786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PD-1 Drug (Nivolumab) May Induce Acute and Life-Threatening Pancreatitis in Lung Cancer Patient: A Case Report.
    Jiang R; Xu L; Huang Y; Fang C; Guo H; Li S; Wu J; Du Z
    Pancreas; 2018 Sep; 47(8):e53-e54. PubMed ID: 30113432
    [No Abstract]   [Full Text] [Related]  

  • 14. Programmed cell death 1 blockade-induced cutaneous sarcoid-like epithelioid granulomas in advanced melanoma: a case report.
    Ogawa T; Ishitsuka Y; Iwamoto K; Koguchi-Yoshioka H; Tanaka R; Watanabe R; Fujisawa Y; Fujimoto M
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e260-e261. PubMed ID: 29314333
    [No Abstract]   [Full Text] [Related]  

  • 15. Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.
    Anastasopoulou A; Papaxoinis G; Diamantopoulos P; Christofidou E; Benopoulou O; Stratigos A; Gogas H
    J Immunother; 2018 Apr; 41(3):164-167. PubMed ID: 29309291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune checkpoint inhibitors and endocrinological side effects].
    Jørgensen LB; Bastholt L; Yderstræde K
    Ugeskr Laeger; 2017 Dec; 179(49):. PubMed ID: 29212592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Nivolumab-Induced Isolated Adrenocorticotropic Hormone Deficiency Presenting Dyspnea].
    Ito K; Uchida T; Manabe Y; Miyazaki Y; Itoh H; Mishina M; Okuno H
    Hinyokika Kiyo; 2018 Oct; 64(10):391-395. PubMed ID: 30543736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.
    Finkelmeier F; Czauderna C; Perkhofer L; Ettrich TJ; Trojan J; Weinmann A; Marquardt JU; Vermehren J; Waidmann O
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):253-259. PubMed ID: 30374657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
    Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
    Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma.
    Tokumo K; Masuda T; Miyama T; Miura S; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Yoshida T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Lung Cancer; 2018 May; 119():21-24. PubMed ID: 29656748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.